中华血液学杂志
中華血液學雜誌
중화혈액학잡지
Chinese Journal of Hematology
2014年
10期
891-896
,共6页
李芳%吕军强%段永娟%孙仪%李栋%汪运山%胡晓%肖东杰
李芳%呂軍彊%段永娟%孫儀%李棟%汪運山%鬍曉%肖東傑
리방%려군강%단영연%손의%리동%왕운산%호효%초동걸
胎儿骨髓%间质干细胞%细胞增殖%免疫调节%细胞因子类
胎兒骨髓%間質榦細胞%細胞增殖%免疫調節%細胞因子類
태인골수%간질간세포%세포증식%면역조절%세포인자류
Fetal bone marrow%Mesenchymal stem cells%Cell proliferation%Immunomodulation%Cytokines
目的 观察胎儿骨髓间充质干细胞(FBM-MSC)对成人外周血淋巴细胞的免疫调控作用及机制.方法 取妊娠14~ 22周龄胎儿骨髓,分离、培养FBM-MSC,通过观察细胞形态、细胞表面分子标志及成骨、成脂分化潜能等进行鉴定;将FBM-MSC与用荧光染料CFSE标记的成人外周血单个核细胞,在PHA刺激条件下共培养5d后,用流式细胞术分析刺激活化后的淋巴细胞增殖情况;用ELISA法检测共培养上清中IFN-γ和TNF-α等炎性因子水平;用荧光实时定量RT-PCR法检测IDO、TSG-6和TGF-β等免疫抑制性因子表达水平.结果 分离的FBM-MSC表面高表达CD29、CD44、CD49e、CD73、CD90、CD105;低表达CD31、CD34、CD45、HLA-DR,具有分化为脂肪和成骨细胞的能力;与单纯PHA刺激后的淋巴细胞相比较,与FBM-MSC共培养抑制淋巴细胞活化增殖,抑制率可高达96%; FBI-MSC共培养还可抑制淋巴细胞分泌炎性因子,对IFN-γ和TNF-α因子分泌的抑制率分别达90.9%和58.4%;与单独培养的FBM-MSC相比较,共培养后的FBM-MSC中重要的免疫调节因子如IDO、TSG-6和TGF-β的表达水平显著上调.结论 胎儿骨髓来源的FBM-MSC对外周血淋巴细胞体外增殖具有明显抑制作用;由MSC分泌的抑制性细胞因子如IDO、TSG-6和TGF-β等在FBM-MSC介导的免疫抑制中可能起重要调节作用.
目的 觀察胎兒骨髓間充質榦細胞(FBM-MSC)對成人外週血淋巴細胞的免疫調控作用及機製.方法 取妊娠14~ 22週齡胎兒骨髓,分離、培養FBM-MSC,通過觀察細胞形態、細胞錶麵分子標誌及成骨、成脂分化潛能等進行鑒定;將FBM-MSC與用熒光染料CFSE標記的成人外週血單箇覈細胞,在PHA刺激條件下共培養5d後,用流式細胞術分析刺激活化後的淋巴細胞增殖情況;用ELISA法檢測共培養上清中IFN-γ和TNF-α等炎性因子水平;用熒光實時定量RT-PCR法檢測IDO、TSG-6和TGF-β等免疫抑製性因子錶達水平.結果 分離的FBM-MSC錶麵高錶達CD29、CD44、CD49e、CD73、CD90、CD105;低錶達CD31、CD34、CD45、HLA-DR,具有分化為脂肪和成骨細胞的能力;與單純PHA刺激後的淋巴細胞相比較,與FBM-MSC共培養抑製淋巴細胞活化增殖,抑製率可高達96%; FBI-MSC共培養還可抑製淋巴細胞分泌炎性因子,對IFN-γ和TNF-α因子分泌的抑製率分彆達90.9%和58.4%;與單獨培養的FBM-MSC相比較,共培養後的FBM-MSC中重要的免疫調節因子如IDO、TSG-6和TGF-β的錶達水平顯著上調.結論 胎兒骨髓來源的FBM-MSC對外週血淋巴細胞體外增殖具有明顯抑製作用;由MSC分泌的抑製性細胞因子如IDO、TSG-6和TGF-β等在FBM-MSC介導的免疫抑製中可能起重要調節作用.
목적 관찰태인골수간충질간세포(FBM-MSC)대성인외주혈림파세포적면역조공작용급궤제.방법 취임신14~ 22주령태인골수,분리、배양FBM-MSC,통과관찰세포형태、세포표면분자표지급성골、성지분화잠능등진행감정;장FBM-MSC여용형광염료CFSE표기적성인외주혈단개핵세포,재PHA자격조건하공배양5d후,용류식세포술분석자격활화후적림파세포증식정황;용ELISA법검측공배양상청중IFN-γ화TNF-α등염성인자수평;용형광실시정량RT-PCR법검측IDO、TSG-6화TGF-β등면역억제성인자표체수평.결과 분리적FBM-MSC표면고표체CD29、CD44、CD49e、CD73、CD90、CD105;저표체CD31、CD34、CD45、HLA-DR,구유분화위지방화성골세포적능력;여단순PHA자격후적림파세포상비교,여FBM-MSC공배양억제림파세포활화증식,억제솔가고체96%; FBI-MSC공배양환가억제림파세포분비염성인자,대IFN-γ화TNF-α인자분비적억제솔분별체90.9%화58.4%;여단독배양적FBM-MSC상비교,공배양후적FBM-MSC중중요적면역조절인자여IDO、TSG-6화TGF-β적표체수평현저상조.결론 태인골수래원적FBM-MSC대외주혈림파세포체외증식구유명현억제작용;유MSC분비적억제성세포인자여IDO、TSG-6화TGF-β등재FBM-MSC개도적면역억제중가능기중요조절작용.
Objective To investigate the potential immunomodulatory properties of fetal bone marrow derived mesenchymal stem cells (FBM-MSCs).Methods Mononuclear cells from the bone marrow of second trimester (14-22 wks) fetus were isolated and cultured for the derivation of MSCs.The derived FBM-MSC cells were characterized via morphology,immunophenotyping and the adipogenic and osteogenic differentiation assays.The immunomodulatory properties of FBM-MSC on lymphocytes were evaluated through the co-culture assay with PHA activated adult peripheral blood mononuclear cells (PBMCs).Results Derived FBM-MSCs were CD29+,CD44,CD49e+,CD73,CD90+,CD105+ and CD31,CD34-,CD45,HLA-DR-and can be differentiated into adipocytes and osteocytes.When co-cultured with PHA-activated PBMCs,FBM-MSCs inhibited the proliferation of lymphocytes up to 96% and down-regulated the secretion of inflammatory cytokines such as IFN-γ and TNF-α up to 90.9% and 58.4% respectively.When compared with FBM-MSCs cultured alone,the expression of MSCs derived immunomodulatory cytokines,such as IDO,TSG-6 and TGF-β,was up-regulated significantly in the co-culture system.Conclusions MSC derived from fetal bone marrow demonstrated immunosuppressive effects on adult PBMCs in vitro.MSC-derived cytokines like IDO,TSG-6 and TGF-β may be critical for FBM-MSCs mediated immunosuppressive function.